Federated Hermes
PYXS icon

Federated Hermes’s Pyxis Oncology PYXS Stock Holding History

Federated Hermes’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.92K Sell
2,962
-219
-7% -$419 ﹤0.01% 1863
2026
Q1 		$4.64K Buy
3,181
+1,287
+68% +$1.94K ﹤0.01% 1897
2025
Q4 		$2.18K Buy
+1,894
New +$6.68K ﹤0.01% 1961
2025
Q2 		– Sell
-2,074
Closed -$2.03K – 2166
2025
Q1 		$2.03K Buy
+2,074
New +$2.77K ﹤0.01% 1948

Other funds holding PYXS

GGI
GordonMD Global Investments Beverely Hills, California $207M AUM
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Federated Hermes's PYXS Position: Q2 2026 in Review

Federated Hermes reduced its Pyxis Oncology (PYXS) stake by 6.9% in Q2 2026, selling an estimated $419 and leaving 2,962 shares worth $8.92K. The position accounts for ﹤0.01% of the portfolio, ranked #1863.

Federated Hermes first reported a position in PYXS in Q1 2025 and has held it in 4 quarters since. 76 funds tracked by Wall St. Rank hold PYXS as of Q2 2026.

  • Federated Hermes held 2,962 shares of Pyxis Oncology worth $8.92K as of Q2 2026.
  • Federated Hermes sold 219 Pyxis Oncology shares in Q2 2026, an estimated $419.
  • Pyxis Oncology made up ﹤0.01% of Federated Hermes's portfolio in Q2 2026, its #1863 holding.
  • Federated Hermes first reported a position in Pyxis Oncology in Q1 2025 and has held it in 4 quarters since.
  • 76 funds tracked by Wall St. Rank held Pyxis Oncology as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.